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ABTRACT 
Objective: To develop and validate a simple, rapid, accurate and precise RP-HPLC method for the simultaneous determination of olmesartan 
medoxomil (OLM) and chlorthalidone (CHL) in pharmaceutical formulation.  
Methods: Chromatographic separation was performed on a Phenomenox, Gemini C18 (250×4.6 mm, 5 µm) column from thermo isocratic mode 
with mobile phase 55:45 water: acetonitrile with pH adjusted to 3.0 with ortho phosphoric acid at flow rate 1 ml/min. Peak intensity of both the 
drugs was monitored at 250 nm with UV detection.  
Results: The retention time (RT) of OLM and CHL was found to be 2.95 and 3.91 min, respectively. The linearity of OLM and CHL were found in the 
range of 10-60 µg/ml for OLM and 5-30 µg/ml for CHL. The limit of detection and limit of quantitation was 15ng/ml and 70 ng/ml for OLM and 20 
ng/ml and 60 ng/ml for CHL.  
Conclusion: The proposed method was validated in terms of accuracy, precision, linearity, limit of detection and limit of quantification. 
Furthermore, no interference was observed with extra pharmacopoeial excipients in tablet suggesting its utility for routine quality control analysis 
of OLM and CHL in pharmaceutical formulations.  
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INTRODUCTION  
Olmesartan medoxamil (OLM) is a (5-methyl-2 oxo-1,3-dioxol-4-yl) 
methyl ester of 4-(1-hydroxy-1-methylethyl)-2-propyl-1{[2-(1H-
tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate 
[1,2] (fig. 1A). It is an AT1 subtype angiotensin II receptor antagonist 
used in the treatment of hypertension. Chlorthalidone (CHL) is an 
oral diuretic used along with oral antihypertensive agent. 
Chemically it is (RS) 2-chloro-5-(1-hydroxy-3-oxo-2, 3-dihydro-1H-
isoindol-1-yl) benzene-1-sulfonamide [3] (fig. 1B). Many analytical 
methods are reported in the literature for the determination of OLM 
by UV-Spectrophotometry [4], RP-HPLC [5-7] and OLM with 
hydrochlorothiazide by HPTLC [8]. Several methods have been 
described for determination of CHL by UV-Spectrophotometry [9], 
RP-HPLC [10-11] and by HPTLC [12]. Although there are several 
chromatographic methods reported for determination of both these 
drugs. However, to the best of our knowledge, there is no LC analytical 
method reported for simultaneous determination of OLM and CHL in 
combined dosage form. The objective of the present work was to 
develop accurate and precise RP-HPLC method with UV-detection for 
the quantification of these drugs in pharmaceutical formulation.  
 
 
Fig. 1: Chemical structures of analytes. A. Olmesartan 
medoxomil, B. Chlorthalidone 
MATERIALS AND METHODS  
Material and reagent 
Olmesartan medoxomil was kind gift of Ajanta pharmaceutical Ltd. 
(Mumbai, India), Chlorthalidone was provided by Ipca laboratories 
(Mumbai, India). Pharmaceutical formulation of tablets containing 
olmesartan medoxomil 20 mg and chlorthalidone 12.5 mg was 
purchased from local market of Nagpur. HPLC grade acetonitrile and 
phosphoric acid was procured from Merck, Mumbai. Double distilled 
de-ionized water was used throughout the study. All solutions were 
filtered through a Millipore vacuum filter system (0.22 µm) and 
degassed by sonicator.  
Instrument 
A HPLC system consisted of LC solution data handling system 
(Shimadzu LC-20AD), a SPD-20A Shimadzu UV visible detector, 
Rheodyne injector with 20 µl sample loop. A 25 µl Hamilton syringe 
was used for injecting the samples. Data acquisition were performed 
by using LC 2010 solution software. Ultrasonic bath sonicator was 
used for degassing of the mobile phase. Weighing of the materials 
was carried on a Shimadzu balance with high accuracy.  
Chromatographic condition 
The mobile phase consisted of water and acetonitrile (55:45 v/v), 
pH of which is maintained at 3.0 using orthophosphoric acid (85%). 
The mobile phase was always freshly prepared and filtered through 
a Millipore vacuum filter system equipped with 0.22 µm filter and 
degassed by sonicator. Chromatography was performed at ambient 
temperature by pumping the mobile phase at a flow rate of 1.0 
ml/min. The column effluent was monitored at 250 nm.  
Standard and working standard 
Accurately 10 mg of standard OLM and CHL were weighed and 
dissolved into 100 ml mobile phase to obtain the final concentration 
of 100 µg/ml. Appropriate dilutions were made into 10 ml 
volumetric flasks with the mobile phase to produce working 
solutions in the concentrations range 10-60 µg/ml and 5-30 µg/ml 
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for OLM and CHL, respectively. 20 µl of samples were injected into 
the chromatographic system and peak areas were measured.  
Pharmaceutical formulation 
Twenty tablets were crushed in the mortar and the powdered 
equivalent to 20 mg OLM and 12.5 mg of CHL were transferred into 
100 ml volumetric flask and dissolved in the mobile phase. The 
solution was sonicated to dissolve solid powder completely. The 
undissolved material is removed by filtration through Whatman filter 
paper no-41. The volume was made up with the mobile phase and 
further dilutions were made with the mobile phase to get final 
concentrations of 20 µg/ml of OLM and 12.5 µg/ml of CHL. The 
solutions were injected and respective Chromatogram was recorded.  
RESULTS AND DISCUSSION  
Method development 
Different trials were carried out by varying the ratio of water: 
acetonitrile (v/v) and optimizing the chromatographic conditions. 
The mobile phase consisting of water: acetonitrile (55: 45 v/v), pH 
3.0 was found to have good resolution at wavelength 250 nm with 
1.0 ml/min flow rate. The optimized conditions give well resolved 
and sharp peak for both the drugs (fig. 2). Retention times for OLM 
and CHL were determined as 2.95 and 3.91 min, respectively (fig. 3). 
 
 
Fig. 2: A typical chromatogram showing well resolved and sharp 
peaks of OLM and CHL 
 
Fig. 3: Representative chromatogram of OLM and CHL having RT 
2.95 and 3.91 min respectively 
 
Method validation 
Method validation was carried out for different parameters 
including linearity, accuracy, inter-day and intra-day precision, 
reproducibility. The limit of detection (LOD) and limit of 
quantification (LOQ), was also determined. All the parameters were 
studied considering the ICH guidelines [13].  
System suitability 
The efficiency of the column is expressed in terms of system 
suitability parameters, such as number of theoretical plates, 
resolution, tailing factor. The data are summarized in table 1. 
Linearity  
The linearity of the method was determined at six concentration 
levels ranging from 10-60 µg/ml for OLM and 5-30 µg/ml for CHL. 
The calibration curve was constructed by plotting peak area against 
concentration of drugs (fig. 4 and 5).  
The results show that an excellent correlation exists between the 
peak area and concentration of drugs. Table 2, lists the linearity 
parameters of the calibration curves for OLM and CHL. 
 
Table 1: System suitability parameter 
Parameters Retention time (tr) Theoretical plates (N) Tailing factor (Tf) Resolution (Rs) 
OLM     
pH     
2.9 2.97 4312 1.67 0.864 
3.0 2.96 4851 1.49 0.504 
3.1 2.95 4765 1.64 0.626 
Flow rate     
0.9 3.29 4995 1.48 0.652 
1.0 2.94 4895 1.47 0.566 
1.1 2.52 4754 1.67 0.588 
Mobile phase     
43:57 2.85 4696 1.52 0.675 
45:55 2.94 4725 1.49 0.525 
47:53 3.12 4915 1.50 0.618 
CHL     
pH     
2.9 3.89 6958 1.74 5.989 
3.0 3.91 7551 1.69 5.718 
3.1 3.88 7842 1.66 5.700 
Flow rate     
0.9 4.34 7154 1.65 5.738 
1.0 3.94 7581 1.66 5.506 
1.1 3.47 7652 1.64 5.593 
Mobile phase     
43:57 3.90 7287 1.66 5.824 
45:55 3.91 7425 1.65 5.542 
47:53 3.92 7894 1.79 5.620 
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Fig. 4: Standard calibration curve of olmesartan medoxomil 
 
 
Fig. 5: Standard calibration curve of chlorthalidone 
Accuracy  
The accuracy of analytical procedure measures the closeness of 
measured values to the true value. Standard solution of accuracy of 
80%, 100% and 120% solutions were injected into the 
chromatographic system. Table 3, represents the high percent 
recovery values indicating that the proposed method is accurate and 
reproducible. 
 








Slope (m) 49679 39084 
Intercept (b) 41346 6954 
LOD (ng/ml) 15 20 
LOQ (ng/ml) 70 60 
 
Precision 
The precision of the method was evaluated by inter day and 
Intraday variation studies. In the intraday studies, six repeated 
injections of standard and sample solutions were made and the 
response factor of drug peaks and percentage of RSD were 
calculated. In the inter day variation studies, six repeated injections 
of standard and sample solutions were made for three consecutive 
days and the response factor of drug peaks and percentage of RSD 
were calculated. From the result obtained table 4, the proposed 
HPLC method was found to be precise. 
 
Table 3: Result for recovery studies 
Analytes Label claim Amount added (%) Total amount (mg) Amount recovered* (mg) Mean recovery (%) RSD(%) 
Olmesartan 
medoxomil 
20 mg/tab 80 16 15.94 99.69±0.49 0.49 
  100 20 19.96 99.80±1.20 1.20 
120 24 23.86 99.43±0.21 0.21 
Chlorthalidone 12.50 
mg/tab 
80 10 9.92 99.30±0.18 0.18 
  100 12.5 12.41 99.32±0.86 0.86 
120 15 14.91 99.45±0.31 0.31 
 * Mean of three determinations 
 
Table 4: Result of precision study 
  %Mean*  SD % RSD 
 OLM CHL OLM CHL OLM CHL 
Intraday precision 99.55 99.14 0.42 1.026 0.42 1.03 
Inter-day precision 99.41 99.47 0.68 1.048 0.68 1.05 
* Mean of six determinations 
 
Detection and quantitation limits  
The limit of detection (LOD) and limit of quantitation (LOQ) of the 
developed method was determined by injecting progressively low 
concentrations of the standard solution using the developed RP-
HPLC method. The LOD is the smallest concentration of analyte that 
gives measurable response. The LOD of OLM and CHL was found to 
be 20 ng/ml and 15 ng/ml, respectively. LOQ was 70 ng/ml and 60 
ng/ml for OLM and CHL, respectively.  
Robustness  
Robustness of the method was determined by making slight changes 
in the chromatographic conditions. It has been observed that the 
proposed method is able to withstand relatively minor alterations in 
pH, compositions of mobile phase and flow rate (table 1), but 
retention times for OLM and CHL were found to be altered. 
CONCLUSION 
The RP-HPLC method was developed and validated successfully in 
terms of accuracy, precision, linearity etc. The proposed method was 
found to be simple, rapid and accurate. Hence, this method can be 
used for easy and efficient routine analysis of OLM and CHL in the 
quality control laboratory.  
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